These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16474312)

  • 1. [Chronic fatigue syndrome in cardiology neurohumoral changes].
    Iasiukiavichene L; Vasiliauskas D
    Kardiologiia; 2006; 46(1):58-64. PubMed ID: 16474312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of early childhood trauma on hypothalamic-pituitary-adrenal (HPA) axis function in patients with Chronic Fatigue Syndrome.
    Kempke S; Luyten P; De Coninck S; Van Houdenhove B; Mayes LC; Claes S
    Psychoneuroendocrinology; 2015 Feb; 52():14-21. PubMed ID: 25459889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways.
    Morris G; Anderson G; Maes M
    Mol Neurobiol; 2017 Nov; 54(9):6806-6819. PubMed ID: 27766535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals.
    Glass JM; Lyden AK; Petzke F; Stein P; Whalen G; Ambrose K; Chrousos G; Clauw DJ
    J Psychosom Res; 2004 Oct; 57(4):391-8. PubMed ID: 15518675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome.
    Gaab J; Engert V; Heitz V; Schad T; Schürmeyer TH; Ehlert U
    J Psychosom Res; 2004 Apr; 56(4):419-24. PubMed ID: 15094026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HPA axis and the genesis of chronic fatigue syndrome.
    Cleare AJ
    Trends Endocrinol Metab; 2004 Mar; 15(2):55-9. PubMed ID: 15036250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The HPA axis in the pathogenesis of chronic fatigue syndrome].
    Ursini F; Succurro E; Grembiale A; Gagliardi DA; Arturi F
    Clin Ter; 2010; 161(5):461-4. PubMed ID: 20949245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research progress in the treatment of chronic fatigue syndrome through interventions targeting the hypothalamus-pituitary-adrenal axis.
    Zhang YD; Wang LN
    Front Endocrinol (Lausanne); 2024; 15():1373748. PubMed ID: 38660512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats.
    Surapaneni DK; Adapa SR; Preeti K; Teja GR; Veeraragavan M; Krishnamurthy S
    J Ethnopharmacol; 2012 Aug; 143(1):91-9. PubMed ID: 22771318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome.
    Tanriverdi F; Karaca Z; Unluhizarci K; Kelestimur F
    Stress; 2007 Mar; 10(1):13-25. PubMed ID: 17454963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Low cortisol production in chronic stress. The connection stress-somatic disease is a challenge for future research].
    Rosmond R; Björntorp P
    Lakartidningen; 2000 Sep; 97(38):4120-4. PubMed ID: 11068377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
    Inder WJ; Prickett TC; Mulder RT
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):343-8. PubMed ID: 15730417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis.
    Fuite J; Vernon SD; Broderick G
    Genomics; 2008 Dec; 92(6):393-9. PubMed ID: 18775774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A PSYCHIATRIST'S PERSPECTIVES ON STRESS, STEROIDS AND MENTAL ILLNESS.
    Dunai M
    Ideggyogy Sz; 2014 Mar; 67(3-4):113-5. PubMed ID: 26118252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hypothalamic-pituitary-adrenal axis in common skin diseases: evidence of its association with stress-related disease activity.
    Kim JE; Cho BK; Cho DH; Park HJ
    Acta Derm Venereol; 2013 Jul; 93(4):387-93. PubMed ID: 23462974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic fatigue syndrome: a stress disorder?
    Cleare AJ; Wessely SC
    Br J Hosp Med; 1996 May 1-14; 55(9):571-4. PubMed ID: 8735034
    [No Abstract]   [Full Text] [Related]  

  • 18. Human models in acute and chronic stress: assessing determinants of individual hypothalamus-pituitary-adrenal axis activity and reactivity.
    Kudielka BM; Wüst S
    Stress; 2010 Jan; 13(1):1-14. PubMed ID: 20105052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia).
    Young AH; Sharpe M; Clements A; Dowling B; Hawton KE; Cowen PJ
    Biol Psychiatry; 1998 Feb; 43(3):236-7. PubMed ID: 9494707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans.
    Miller GE; Chen E; Zhou ES
    Psychol Bull; 2007 Jan; 133(1):25-45. PubMed ID: 17201569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.